Analyst consensus rating
Adicet Bio Analyst Rating: none
Direct answer
Adicet Bio's consensus rating is none.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $34.83.
Forecast evidence checked November 3, 2026.
Get free Adicet Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.20
- Average price target
- $34.83
- High price target
- $90.00
- Low price target
- $18.00
- Low target gap
- +462.5%
- Target upside
- +988.5%
- High target gap
- +2,712.5%
- Target range width
- 2,250%
- Consensus rating
- none
- Analysts
- 6
- Evidence date
- November 3, 2026
- Valid through
- November 10, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Adicet Bio?
Adicet Bio has a verified none consensus. The same dataset has an average price target of $34.83.
How far are Adicet Bio's low and high targets from the recorded price?
The low target implies +462.5%, while the high target implies +2,712.5%.
How many analysts are included in Adicet Bio's consensus?
The verified consensus includes 6 analysts.
How is Adicet Bio's target upside or downside calculated?
The average target of $34.83 is divided by the recorded price of $3.20, then one is subtracted to produce +988.5%. This does not guarantee a future return.
When was Adicet Bio's analyst forecast verified?
The data was verified on 2026-11-03. The dataset is valid through 2026-11-10.